Amplification of CDK4 and MDM2 in malignant melanoma

Muthusamy, Viswanathan, Hobbs, Cara, Nogueira, Cristina, Cordon‐Cardo, Carlos, McKee, Phillip H., Chin, Lynda, Bosenberg, Marcus W.·2006·Genes Chromosomes and Cancer
DOI 10.1002/gcc.20310

Cited by (150)

Items 101–150 of 150

  1. Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers—An Overview
    Ramya Mathiyalagan, Anjali Kariyarath Valappil, Deok‐Chun Yang, Se Chan Kang, Thavasyappan Thambi · 2022 · Gels
  2. The HGF/SF Mouse Model of UV-Induced Melanoma as an In Vivo Sensor for Metastasis-Regulating Gene
    M. Kathryn Leonard, Nidhi Pamidimukkala, Gemma S. Puts, Devin E. Snyder, Andrzej T. Slominski, David M. Kaetzel · 2017 · International Journal of Molecular Sciences
  3. Genome-scale search of tumor-specific antigens by collective analysis of mutations, expressions and T-cell recognition
    Jia Jia, Juan Cui, Xianghui Liu, Jin-Hua Han, Shengyong Yang, Yuquan Wei, Yu Chen · 2009 · Molecular Immunology
  4. Pocket protein function in melanocyte homeostasis and neoplasia
    Ian D. Tonks, Nicholas K. Hayward, Graham F. Kay · 2006 · Pigment Cell Research
  5. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c‑Myc and p53 substrates in patients with dysplastic nevi or melanoma
    Julija Mozūraitienė, Živilė Gudlevičienė, Ieva Vincerževskienė, Aida Laurinavičienė, Justinas Pamedys · 2020 · Oncology Letters
  6. Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
    Charmy Twala, Sibusiso Tebogo Malindisa, Chamoné Munnik, Selisha Ann Sooklal, Monde McMillan Ntwasa · 2025 · Biomedicines
  7. Pleiotropy between Genetic Markers of Obesity and Risk of Prostate Cancer
    Todd L. Edwards, Ayush Giri, Saundra S. Motley, Wynne Duong, Jay H. Fowke · 2013 · Cancer Epidemiology Biomarkers & Prevention
  8. Melanoma Pathogenesis
    Jennifer A. Lo, David E. Fisher · 2014 · Cancer drug discovery and develogment/Cancer drug discovery and development
  9. Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanoma.
    Philip J Eliades, K. Flaherty, H. Tsao · 2015 · Melanoma Management
  10. p53 Regulation by TRP2 Is Not Pervasive in Melanoma
    Roland Houben, Corinna P. Schmid, Melissa Maier, Marion Wobser, Stephanie Motschenbacher, Jürgen Christian Becker, Claudia S. Vetter‐Kauczok, Gerhard H. Weyandt, Sonja Hesbacher, Sebastian Haferkamp · 2014 · PLoS ONE
  11. The rise of new targets in melanoma
    Xue Li Bai, Keith T. Flaherty · 2025 · British Journal of Dermatology
  12. Exploring Molecular Characteristics and Therapeutic Strategies for Primary Sinonasal Mucosal Melanoma With Distant Metastasis
    Dong Ren, Chenchen Niu, Nyein Nyein Htun, Xin Zhang, Jiadi He, Ronggang Li, Qiongru Liu, Vincent Lee, Robert A. Edwards, Grace Guoying Zhou et al. · 2025 · Laboratory Investigation
  13. Melanocyte homeostasis in vivo tolerates Rb1 loss in a developmentally independent fashion
    Ian D. Tonks, Arne W. Mould, Wayne A. Schroder, Elke Hacker, Marcus Bosenberg, Nicholas K. Hayward, Graeme J. Walker, Graham F. Kay · 2010 · Pigment Cell & Melanoma Research
  14. Expression profile of metastasis-associated genes in esophageal squamous cell carcinoma
    Pei Li, Ling Zhi-qiang, Yong Hongyan, Huang Youtian, Zhao Mingyao, Zheng Zhimin, Dong Ziming · 2006 · Journal of Huazhong University of Science and Technology [Medical Sciences]
  15. Pathology and Molecular Pathology of Melanoma
    Amrita Goyal, Lyn McDivitt Duncan · 2016 · Springer eBooks
  16. Identification and characterization of BRAF⇔TP53 interactions in melanoma
    Kayla T. O’Toole, Adamaris Martinez, Brandon Murphy, Gabriela Fort, Fatima Al-Sudani, Anastasia Prokofyeva, Sanjana Srinivas Boggaram, Eric A. Smith, Elliott L. Paine, Deevya Baral et al. · 2026 · Cell Reports
  17. Evaluation of immunohistochemical expression of MDM2 protein in comparison with MDM2 gene amplification in diagnosing lipomatous tumors
    Hanan Mohamed Abd Elmoneim, Yaser Makram El Sherbiny · 2011 · Egyptian Journal of Pathology
  18. Melanoma Genetics and Genomics
    Allen Ho, Goran B Jönsson, Hensin Tsao · 2017 · Springer eBooks
  19. Melanoma Genetics: From Susceptibility to Progression
    Guilherme Francisco, Priscila Daniele Ramos Cirilo, Fernanda Toledo, Tharcísio Citrângulo Tortelli, Roger J. Chammas · 2013 · InTech eBooks
  20. Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes
    Xuan Tien Steven Nguyen, Ian R. Watson · 2018 · Springer eBooks
  21. Role of X-Linked Inhibitor of Apoptosis Protein in Therapeutic Resistance of Inflammatory Breast Cancer Cells
    Katherine M. Aird · 2010 · DukeSpace (Duke University)
  22. Cancer Genomics and Evolution
    William P.D. Hendricks, Aleksandar Sekulić, Alan Haruo Bryce, Muhammed Murtaza, Pilar Ramos, Jeffrey M. Trent · 2017 · Wiley eBooks
  23. Characterization of the BRAF interactome identifies BRAF V600E <=>TP53 interaction in melanoma
    Kayla T. O’Toole, Adamaris Martinez, Brandon Murphy, Anastasia Proveyeka, Gabriela Fort, Fatima Al-Sudani, Sanjana Srinivas Boggaram, Elliott L. Paine, Deevya Baral, Joshua Lyon Andersen et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Targeting the Cell Cycle and p53 in Combination with BRAF-Directed Therapy
    Dale Han, Keiran S.M. Smalley · 2014 · Cancer drug discovery and develogment/Cancer drug discovery and development
  25. Signaling Networks that Induce Melanomagenesis and Metastasis that can be Exploited for Therapeutic Benefit
    Eden Elizabeth Tanzosh · 2013
  26. Classification of Breast Cancer Patients and NCI-60 Cell Lines Using a Novel SNV-based Phylogenetic Analysis Method
    William J. Faison · ProQuest Demo Repository
  27. Resolving mechanisms of apoptosis in response to WNT3A in Melanoma
    William H. Conrad · 2012 · ResearchWorks at the University of Washington (University of Washington)
  28. Melanoma
    Adina Vultur, Keiran S.M. Smalley, Meenhard Herlyn · 2013 · Cambridge University Press eBooks
  29. Funktionelle Charakterisierung der Gliom-amplifizierten Sequenz GAS41 während der Mitose
    Sabrina Heisel · 2009 · Publications of the UdS (Saarland University)
  30. Melanoma: Treatments and Resistance
    Jonathan Castillo, Miriam Galvonas Jasiulionis · 2013 · InTech eBooks
  31. Towards new therapeutic strategies in chondrosarcoma
    Yvonne M. Schrage · 2009 · Leiden Repository (Leiden University)
  32. Extracellular Vesicles and RNA interference in tumors
    Taral R. Lunavat · 2016 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  33. New Approaches to Signaling
    R. Sullivan, K. Flaherty · 2017 · Springer eBooks
  34. The role of MITF in the regulation of CDKN2A in melanoma
    Randi Christel Andreassen · 2017 · NORA - Norwegian Open Research Archives
  35. Genetic Mutations and Ubiquitination in Melanoma Growth and Metastasis
    Anushka Dikshit, Jennifer Y. Zhang · 2018 · IntechOpen eBooks
  36. MAPK-induced miR-29 targets MAFG and suppresses melanoma development
    Olga Vera, Ilah Bok, Neel Jasani, Koji Nakamura, Xiaonan Xu, Nicol Mecozzi, Ariana Angarita, Kaizhen Wang, Kenneth Yee Tsai, Florian A. Karreth · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Melanoma Genetics and Genomics
    Goran B Jönsson, Hensin Tsao · 2011 · Springer eBooks
  38. Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes
    Xuan Tien Steven Nguyen, Ian R. Watson · 2019 · Springer eBooks
  39. Cancer Genomics and Evolution
    William P.D. Hendricks, Aleksandar Sekulić, Alan Haruo Bryce, Muhammed Murtaza, Pilar Ramos, Jessica D. Lang, Timothy G. Whitsett, Timothy K. McDaniel, Russell C. Rockne, Nicholas E. Banovich et al. · 2022 · Wiley eBooks
  40. Ezetimibe anticancer activity via the p53/Mdm2 pathway: Implications for RBBP6
    Charmy Twala, Bonnie Russell, Sibusiso Tebogo Malindisa, Chamoné Munnik, Selisha Ann Sooklal, Monde McMillan Ntwasa · 2024 · Research Square
  41. New Therapeutic Approaches in Signaling
    Keith T. Flaherty · 2011 · Springer eBooks
  42. Additional file 1 of Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing
    Zhao, Yue, Jun Ying He, Cui, Jun Zhao, Meng, Zi-Qi, Zou, Yue Li, Xiao Su Guo, Chen, Xin, Wang, Xueliang, Yan, Li-Tian, Han, Wei Xin et al. · 2020 · Figshare
  43. N-terminal isoforms of the p53 tumour suppressor protein : effects on p53 transcriptional activity and expression in cutaneous melanoma
    Hind Hafsi · 2012
  44. Epigenetic regulation of gene expression during melanocyte and melanoma development
    Patrick Laurette · 2016 · theses.fr (ABES)
  45. Mise en évidence d'un rôle suppresseur de tumeur pour la protéine tyrosine-kinase FES dans le mélanome
    Julie C. Tisserand · 2016
  46. Rôle pro-tumorigénique de HACE1 dans le mélanome
    Najla El Hachem · 2017 · theses.fr (ABES)
  47. Développement préclinique d’un nouveau composé anti-mélanome : activation des voies AMPK et p53 pour induire la mort des cellules de mélanome
    Emilie Jaune · 2018 · theses.fr (ABES)
  48. Biologie des tumeurs conjonctives de malignité intermédiaire : le modèle des tumeurs fibreuses solitaires méningées
    Nicolas Macagno · 2019
  49. Rôle de c-Jun dans la réponse aux inhibiteurs de la voie des MAPK dans les mélanomes
    Magdalena Pohorecka · 2018 · theses.fr (ABES)
  50. BindingDB Entry 50006863: Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines.
    BindingDB · 2021 · UC San Diego